Enzo Biochem, Inc.

NYSE:ENZ

1.12 (USD) • At close September 6, 2024
Bedrijfsnaam Enzo Biochem, Inc.
Symbool ENZ
Munteenheid USD
Prijs 1.12
Beurswaarde 57,632,624
Dividendpercentage 0%
52-weken bereik 0.99 - 1.5
Industrie Diagnostics & Research
Sector Healthcare
CEO Ms. Kara Cannon
Website https://www.enzo.com

An error occurred while fetching data.

Over Enzo Biochem, Inc.

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and

Vergelijkbare Aandelen

Vapotherm, Inc. logo

Vapotherm, Inc.

VAPO

2.16 USD

Annovis Bio, Inc. logo

Annovis Bio, Inc.

ANVS

7.87 USD

Ambrx Biopharma Inc. logo

Ambrx Biopharma Inc.

AMAM

28 USD

Sonendo, Inc. logo

Sonendo, Inc.

SONX

0.063 USD

Sonida Senior Living, Inc. logo

Sonida Senior Living, Inc.

SNDA

26.92 USD

Rafael Holdings, Inc. logo

Rafael Holdings, Inc.

RFL

1.51 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)